Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum

ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are co...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 102; no. 8; pp. 2814 - 2824
Main Authors Schorr, Melanie, Marengi, Dean A, Pulumo, Reitumetse L, Yu, Elaine, Eddy, Kamryn T, Klibanski, Anne, Miller, Karen K, Lawson, Elizabeth A
Format Journal Article
LanguageEnglish
Published Washington, DC Endocrine Society 01.08.2017
Copyright Oxford University Press
Oxford University Press
Subjects
Online AccessGet full text
ISSN0021-972X
1945-7197
1945-7197
DOI10.1210/jc.2016-3963

Cover

Loading…
Abstract ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.DesignCross-sectional.SettingClinical research center.ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum.
AbstractList Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum.
Abstract Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown. To determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum. Cross-sectional. Clinical research center. Fifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19). Serum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry. OXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant. These data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment. Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum.
Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown. To determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum. Cross-sectional. Clinical research center. Fifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19). Serum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry. OXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant. These data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.
Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.To determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.Cross-sectional.DesignCross-sectional.Clinical research center.SettingClinical research center.Fifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Serum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.OXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.These data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.
ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.DesignCross-sectional.SettingClinical research center.ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.
ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown.ObjectiveTo determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum.DesignCross-sectional.SettingClinical research center.ParticipantsFifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19).Main Outcome MeasuresSerum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry.ResultsOXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant.ConclusionsThese data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone density and strength across the weight spectrum.
Author Marengi, Dean A
Lawson, Elizabeth A
Pulumo, Reitumetse L
Schorr, Melanie
Miller, Karen K
Eddy, Kamryn T
Klibanski, Anne
Yu, Elaine
AuthorAffiliation 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 2Harvard Medical School, Boston, Massachusetts 02115 3Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 4Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts 02114
AuthorAffiliation_xml – name: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 2Harvard Medical School, Boston, Massachusetts 02115 3Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114 4Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts 02114
Author_xml – sequence: 1
  givenname: Melanie
  surname: Schorr
  fullname: Schorr, Melanie
  organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
– sequence: 2
  givenname: Dean A
  surname: Marengi
  fullname: Marengi, Dean A
  organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
– sequence: 3
  givenname: Reitumetse L
  surname: Pulumo
  fullname: Pulumo, Reitumetse L
  organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
– sequence: 4
  givenname: Elaine
  surname: Yu
  fullname: Yu, Elaine
  organization: 2Harvard Medical School, Boston, Massachusetts 02115
– sequence: 5
  givenname: Kamryn T
  surname: Eddy
  fullname: Eddy, Kamryn T
  organization: 2Harvard Medical School, Boston, Massachusetts 02115
– sequence: 6
  givenname: Anne
  surname: Klibanski
  fullname: Klibanski, Anne
  organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
– sequence: 7
  givenname: Karen K
  surname: Miller
  fullname: Miller, Karen K
  organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
– sequence: 8
  givenname: Elizabeth A
  surname: Lawson
  fullname: Lawson, Elizabeth A
  email: ealawson@partners.org
  organization: 1Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28586943$$D View this record in MEDLINE/PubMed
BookMark eNp9kstv1DAQxiNURB9w44wscYDDpvgVPy5IZYG2UlElHoKb5U0mXS-JHWKHsv893t0WQaVysCyPf9_nmfEcFns-eCiKpwQfE0rwq1V9TDERJdOCPSgOiOZVKYmWe8UBxpSUWtJv-8VhjCuMCecVe1TsU1UpoTk7KNLlr3UKtfPI-gadp4g-QmeTCz4u3YBSQG9Cs0bz0A8huk18liMe0AfnYbQdegs-x9ezrf4sS04h9JDGNTqpxxAjSktAX8FdLRP6NECdxql_XDxsbRfhyc1-VHx5_-7z_Ky8uDw9n59clDWXGpdCCFyRugXMMZPQVKqlQlksGaegsaqtWrR20WSu5VLSZgFUWVZZgoVmGNhR8XrnO0yLHpoafMopm2F0vR3XJlhn_r3xbmmuwk9TVVyoimeDlzcGY_gxQUymd7GGrrMewhQN0Vji3FYiMvr8DroK0-hzeYYRwZnCgtP_UUQLrbWSmGTq2d95_0n49tsyQHfAtsUjtKZ2aftruQzXGYLNZjbMqjab2TCb2cii2R3Rre89ON_h16FLMMbv3XQNo1mC7dLS5KoxF1KVWSCxyqcyL4qz7MVOFqbhvge2s8p-A3BL1PQ
CitedBy_id crossref_primary_10_1016_j_neubiorev_2024_105765
crossref_primary_10_1007_s00223_021_00826_3
crossref_primary_10_3390_medicina58111625
crossref_primary_10_1186_s13148_022_01318_3
crossref_primary_10_1038_s41598_018_20963_4
crossref_primary_10_3390_brainsci13071075
crossref_primary_10_7570_jomes20098
crossref_primary_10_1093_braincomms_fcaa081
crossref_primary_10_3390_ijms24054832
crossref_primary_10_1016_j_clnu_2021_08_011
crossref_primary_10_1016_j_physbeh_2019_112684
crossref_primary_10_1111_cen_13909
crossref_primary_10_1111_dom_13527
crossref_primary_10_1111_obr_12757
crossref_primary_10_1159_000506638
crossref_primary_10_1038_s41366_018_0150_x
crossref_primary_10_1016_j_npep_2023_102387
crossref_primary_10_1210_endrev_bnad033
crossref_primary_10_1016_j_cbpa_2024_111793
crossref_primary_10_1080_21678707_2018_1451326
crossref_primary_10_1210_jc_2019_00643
crossref_primary_10_1007_s11920_018_0957_0
crossref_primary_10_1159_000492001
crossref_primary_10_29252_rbmb_9_2_147
crossref_primary_10_1016_j_cpnec_2024_100242
crossref_primary_10_3389_fnins_2021_743546
crossref_primary_10_3390_ijms22147737
crossref_primary_10_1210_er_2018_00063
crossref_primary_10_1177_02698811241309617
crossref_primary_10_1016_j_physbeh_2024_114777
crossref_primary_10_1007_s40519_024_01698_w
crossref_primary_10_1530_JOE_17_0680
crossref_primary_10_1007_s00213_019_05280_6
crossref_primary_10_1111_dom_15812
crossref_primary_10_1016_j_brainres_2017_09_024
crossref_primary_10_1016_j_pnpbp_2022_110561
crossref_primary_10_2174_0929867329666220727120646
crossref_primary_10_3389_fpsyt_2019_01032
crossref_primary_10_3389_fendo_2022_1049541
crossref_primary_10_1016_j_tem_2021_02_005
crossref_primary_10_1210_endrev_bnad025
crossref_primary_10_1111_jne_12805
crossref_primary_10_1093_ejendo_lvad087
crossref_primary_10_1210_endrev_bnz012
crossref_primary_10_1038_nrendo_2017_115
crossref_primary_10_3390_nu15163509
Cites_doi 10.1210/jc.2014-2104
10.1055/s-0034-1395677
10.1016/0167-0115(87)90045-0
10.1210/jc.2009-1046
10.1111/j.1365-2265.2011.04182.x
10.4088/JCP.10m06617
10.1530/EJE-12-0869
10.1002/oby.20424
10.1210/jc.2013-3190
10.1152/ajpendo.00196.2011
10.1210/jc.2014-2206
10.1210/JC.2015-2078
10.1007/s00198-011-1578-1
10.1634/stemcells.2008-0127
10.1097/WNR.0b013e3283021ca9
10.1210/jc.2013-4126
10.1038/ncomms5082
10.1371/journal.pone.0025565
10.1016/j.jocd.2007.12.001
10.1152/ajpendo.00296.2011
10.1073/pnas.0901890106
10.1016/j.jbspin.2011.02.002
10.1007/BF03350119
10.1002/jbmr.506
10.1073/pnas.1523762113
10.1093/ajcn/51.6.1106
10.1002/oby.21069
10.1530/EJE-15-0875
10.1007/s00198-004-1820-1
10.1249/00005768-199301000-00010
10.1074/jbc.M112.365049
10.1016/0196-9781(91)90176-P
10.1359/jbmr.080802
10.1093/ajcn/37.2.311
10.1210/jc.2013-4136
10.1016/0196-9781(89)90082-X
10.1530/EJE-10-0523
10.1038/ijo.2016.149
ContentType Journal Article
Copyright Copyright © 2017 Endocrine Society 2017
Copyright © Oxford University Press 2015
Copyright © 2017 Endocrine Society
Copyright_xml – notice: Copyright © 2017 Endocrine Society 2017
– notice: Copyright © Oxford University Press 2015
– notice: Copyright © 2017 Endocrine Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7T5
7TM
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1210/jc.2016-3963
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Proquest Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Academic Middle East (New)
MEDLINE
MEDLINE - Academic
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1945-7197
EndPage 2824
ExternalDocumentID PMC5546854
28586943
10_1210_jc_2016_3963
00004678-201708000-00020
10.1210/jc.2016-3963
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: K24 HL092902
– fundername: NCRR NIH HHS
  grantid: UL1 RR025758
– fundername: NIDDK NIH HHS
  grantid: R01 DK052625
– fundername: NIDDK NIH HHS
  grantid: P30 DK040561
– fundername: NIDDK NIH HHS
  grantid: T32 DK007028
– fundername: NICHD NIH HHS
  grantid: K12 HD051959
– fundername: NIMH NIH HHS
  grantid: K23 MH092560
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
3O-
3V.
4.4
48X
53G
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABZA
AACZT
AAIMJ
AAJQQ
AAKAS
AAPGJ
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYJJ
ABBLC
ABDFA
ABDPE
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABUWG
ABVGC
ABWST
ABXVV
ACFRR
ACGFO
ACGFS
ACPRK
ACUTJ
ACYHN
ACZBC
ADBBV
ADGKP
ADGZP
ADHKW
ADQBN
ADRTK
ADVEK
ADZCM
AELWJ
AEMDU
AENEX
AENZO
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFQV
AFFZL
AFGWE
AFKRA
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGQXC
AGUTN
AHMBA
AHMMS
AI.
AJEEA
ALMA_UNASSIGNED_HOLDINGS
APIBT
APJGH
AQDSO
AQKUS
ARIXL
ASPBG
ATGXG
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BENPR
BEYMZ
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CCPQU
CDBKE
CS3
D-I
DAKXR
DIK
E3Z
EBS
EIHJH
EJD
EMOBN
ENERS
F5P
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GJXCC
GX1
H13
HMCUK
HVGLF
HZ~
H~9
IAO
IHR
INH
ITC
J5H
KBUDW
KOP
KQ8
KSI
KSN
L7B
M1P
M5~
MBLQV
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NVLIB
O9-
OAUYM
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
PQQKQ
PROAC
PSQYO
REU
ROX
ROZ
TEORI
TJX
TLC
TMA
TR2
TWZ
UKHRP
VH1
VVN
W8F
WHG
WOQ
X52
X7M
YBU
YFH
YHG
YOC
YSK
ZGI
ZXP
ZY1
~02
~H1
ABXZS
ACVCV
ADMTO
ADNBA
AEMQT
AEOTA
AGORE
AHGBF
AJBYB
AJDVS
ALXQX
AVNTJ
NU-
OBFPC
PHGZM
PHGZT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7T5
7TM
7XB
8FK
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c4790-666051cfe04037ed58f268a07342e908ca8bfabd666f4772dbe28a35a106930e3
IEDL.DBID 7X7
ISSN 0021-972X
1945-7197
IngestDate Thu Aug 21 14:05:33 EDT 2025
Mon Jul 21 11:44:47 EDT 2025
Fri Jul 25 22:10:50 EDT 2025
Fri Jul 25 19:56:39 EDT 2025
Thu Apr 03 07:08:31 EDT 2025
Tue Jul 01 01:10:45 EDT 2025
Thu Apr 24 23:09:10 EDT 2025
Fri May 16 03:50:15 EDT 2025
Fri Feb 07 10:35:21 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License Copyright © 2017 Endocrine Society
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4790-666051cfe04037ed58f268a07342e908ca8bfabd666f4772dbe28a35a106930e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28586943
PQID 1969998701
PQPubID 2046206
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5546854
proquest_miscellaneous_1907000116
proquest_journals_3164380642
proquest_journals_1969998701
pubmed_primary_28586943
crossref_citationtrail_10_1210_jc_2016_3963
crossref_primary_10_1210_jc_2016_3963
wolterskluwer_health_00004678-201708000-00020
oup_primary_10_1210_jc_2016-3963
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-August
PublicationDateYYYYMMDD 2017-08-01
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-August
PublicationDecade 2010
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
– name: Washington
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2017
Publisher Endocrine Society
Copyright Oxford University Press
Oxford University Press
Publisher_xml – name: Endocrine Society
– name: Copyright Oxford University Press
– name: Oxford University Press
References ( key 20170807135912_B4) 2011; 3
( key 20170807135912_B20) 2009; 106
( key 20170807135912_B26) 2005; 16
( key 20170807135912_B10) 1997; 423
( key 20170807135912_B18) 2014; 99
( key 20170807135912_B43) 2012; 27
( key 20170807135912_B32) 2012; 76
( key 20170807135912_B22) 2016; 113
( key 20170807135912_B11) 2015; 23
( key 20170807135912_B35) 1983; 64
( key 20170807135912_B14) 2011; 72
( key 20170807135912_B13) 2013
( key 20170807135912_B31) 2011; 164
( key 20170807135912_B29) 2014; 99
( key 20170807135912_B30) 2009; 94
( key 20170807135912_B36) 1983; 37
( key 20170807135912_B27) 2008; 23
( key 20170807135912_B44) 2013; 21
( key 20170807135912_B19) 2008; 26
( key 20170807135912_B40) 2008; 11
( key 20170807135912_B1) 2008; 19
( key 20170807135912_B16) 1989; 13
( key 20170807135912_B3) 2012; 302
( key 20170807135912_B8) 2011; 6
( key 20170807135912_B12) 2016; 40
( key 20170807135912_B21) 2012; 287
( key 20170807135912_B34) 2016; 174
( key 20170807135912_B38) 1990; 51
( key 20170807135912_B41) 2015; 47
( key 20170807135912_B28) 2014; 99
( key 20170807135912_B17) 1988; 11
( key 20170807135912_B23) 2007; 41
( key 20170807135912_B33) 2015; 100
( key 20170807135912_B7) 2011; 301
( key 20170807135912_B24) 2011; 78
( key 20170807135912_B5) 1989; 10
( key 20170807135912_B25) 2013; 168
( key 20170807135912_B39) 2012; 23
( key 20170807135912_B2) 2014; 5
( key 20170807135912_B9) 1987; 18
( key 20170807135912_B37) 1993; 25
( key 20170807135912_B42) 2014; 99
( key 20170807135912_B6) 1991; 12
( key 20170807135912_B15) 2014; 99
18257653 - Endocr Regul. 2007 Nov;41(4):131-41
2748428 - Peptides. 1989 Jan-Feb;10(1):89-93
19837921 - J Clin Endocrinol Metab. 2009 Dec;94(12):4710-6
21098684 - Eur J Endocrinol. 2011 Feb;164(2):253-61
18684092 - J Bone Miner Res. 2008 Dec;23(12):1892-904
19369205 - Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7149-54
24606095 - J Clin Endocrinol Metab. 2014 May;99(5):E881-5
26903591 - Eur J Endocrinol. 2016 Apr;174(4):503-12
24384013 - J Clin Endocrinol Metab. 2014 Jan;99(1):30-8
25565097 - Horm Metab Res. 2015 Jul;47(8):600-4
23258269 - Eur J Endocrinol. 2013 Feb 20;168(3):457-64
21394495 - Osteoporos Int. 2012 Feb;23(2):543-51
1646995 - Peptides. 1991 Jan-Feb;12(1):113-8
21915902 - J Bone Miner Res. 2012 Jan;27(1):119-24
18520999 - Neuroreport. 2008 Jun 11;19(9):951-5
23700406 - PLoS One. 2013 May 20;8(5):e61477
24915299 - Nat Commun. 2014 Jun 10;5:4082
2819958 - Regul Pept. 1987 Jul;18(1):7-18
23512706 - Obesity (Silver Spring). 2013 Dec;21(12):2458-64
22008455 - Am J Physiol Endocrinol Metab. 2012 Jan 1;302(1):E134-44
26171799 - J Clin Endocrinol Metab. 2015 Sep;100(9):3313-21
2349926 - Am J Clin Nutr. 1990 Jun;51(6):1106-12
18280192 - J Clin Densitom. 2008 Apr-Jun;11(2):232-6
25233153 - J Clin Endocrinol Metab. 2014 Dec;99(12):4683-9
22761429 - J Biol Chem. 2012 Aug 17;287(34):29159-67
6823895 - Am J Clin Nutr. 1983 Feb;37(2):311-4
21781144 - Clin Endocrinol (Oxf). 2012 Apr;76(4):520-5
6623350 - Stat Bull Metrop Life Found. 1983 Jan-Jun;64(1):3-9
25865294 - Obesity (Silver Spring). 2015 May;23(5):950-6
8423758 - Med Sci Sports Exerc. 1993 Jan;25(1):60-70
21980491 - PLoS One. 2011;6(9):e25565
25062461 - J Clin Endocrinol Metab. 2014 Dec;99(12):4664-73
21903023 - J Clin Psychiatry. 2011 Nov;72(11):1546-51
18583541 - Stem Cells. 2008 Sep;26(9):2399-407
22184277 - Aging (Albany NY). 2011 Dec;3(12):1169-77
26699482 - Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):164-9
24446658 - J Clin Endocrinol Metab. 2014 Apr;99(4):E634-41
3283208 - J Endocrinol Invest. 1988 Feb;11(2):125-8
21828335 - Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E1004-12
21441053 - Joint Bone Spine. 2011 Dec;78(6):611-5
27553712 - Int J Obes (Lond). 2016 Nov;40(11):1707-1714
9401539 - Acta Paediatr Suppl. 1997 Nov;423:50-4
2744933 - Int J Obes. 1989;13(2):213-22
15688123 - Osteoporos Int. 2005 May;16(5):460-7
References_xml – volume: 99
  start-page: 4664
  issue: 12
  year: 2014
  ident: key 20170807135912_B29
  article-title: Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-2104
– volume: 47
  start-page: 600
  issue: 8
  year: 2015
  ident: key 20170807135912_B41
  article-title: Differential regulation of oxytocin receptor in various adipose tissue depots and skeletal muscle types in obese Zucker rats
  publication-title: Horm Metab Res
  doi: 10.1055/s-0034-1395677
– volume: 18
  start-page: 7
  issue: 1
  year: 1987
  ident: key 20170807135912_B9
  article-title: Binding and structural properties of oxytocin receptors in isolated rat epididymal adipocytes
  publication-title: Regul Pept
  doi: 10.1016/0167-0115(87)90045-0
– volume: 94
  start-page: 4710
  issue: 12
  year: 2009
  ident: key 20170807135912_B30
  article-title: Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-1046
– volume: 76
  start-page: 520
  issue: 4
  year: 2012
  ident: key 20170807135912_B32
  article-title: Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2011.04182.x
– volume: 72
  start-page: 1546
  issue: 11
  year: 2011
  ident: key 20170807135912_B14
  article-title: Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.10m06617
– volume: 168
  start-page: 457
  issue: 3
  year: 2013
  ident: key 20170807135912_B25
  article-title: Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-12-0869
– volume: 21
  start-page: 2458
  issue: 12
  year: 2013
  ident: key 20170807135912_B44
  article-title: Assessment of abdominal fat compartments using DXA in premenopausal women from anorexia nervosa to morbid obesity
  publication-title: Obesity (Silver Spring)
  doi: 10.1002/oby.20424
– volume: 99
  start-page: 30
  issue: 1
  year: 2014
  ident: key 20170807135912_B28
  article-title: Association between lean mass, fat mass, and bone mineral density: a meta-analysis
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-3190
– volume: 301
  start-page: E1004
  issue: 5
  year: 2011
  ident: key 20170807135912_B7
  article-title: Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00196.2011
– volume: 99
  start-page: 4683
  issue: 12
  year: 2014
  ident: key 20170807135912_B18
  article-title: Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-2206
– volume: 100
  start-page: 3313
  issue: 9
  year: 2015
  ident: key 20170807135912_B33
  article-title: Cortisol measures across the weight spectrum
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/JC.2015-2078
– volume: 423
  start-page: 50
  year: 1997
  ident: key 20170807135912_B10
  article-title: Prader-Willi syndrome and the hypothalamus
  publication-title: Acta Paediatr Suppl
– volume: 13
  start-page: 213
  issue: 2
  year: 1989
  ident: key 20170807135912_B16
  article-title: Elevated plasma levels of oxytocin in obese subjects before and after gastric banding
  publication-title: Int J Obes
– volume: 23
  start-page: 543
  issue: 2
  year: 2012
  ident: key 20170807135912_B39
  article-title: An in vivo comparison of hip structure analysis (HSA) with measurements obtained by QCT
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-011-1578-1
– volume: 26
  start-page: 2399
  issue: 9
  year: 2008
  ident: key 20170807135912_B19
  article-title: Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2008-0127
– volume: 19
  start-page: 951
  issue: 9
  year: 2008
  ident: key 20170807135912_B1
  article-title: Oxytocin receptor-deficient mice developed late-onset obesity
  publication-title: Neuroreport
  doi: 10.1097/WNR.0b013e3283021ca9
– volume: 99
  start-page: E634
  issue: 4
  year: 2014
  ident: key 20170807135912_B42
  article-title: Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-4126
– volume: 5
  start-page: 4082
  year: 2014
  ident: key 20170807135912_B2
  article-title: Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration
  publication-title: Nat Commun
  doi: 10.1038/ncomms5082
– volume: 6
  start-page: e25565
  issue: 9
  year: 2011
  ident: key 20170807135912_B8
  article-title: Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0025565
– volume: 11
  start-page: 232
  issue: 2
  year: 2008
  ident: key 20170807135912_B40
  article-title: Comparison of DXA hip structural analysis with volumetric QCT
  publication-title: J Clin Densitom
  doi: 10.1016/j.jocd.2007.12.001
– volume: 3
  start-page: 1169
  issue: 12
  year: 2011
  ident: key 20170807135912_B4
  article-title: Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass
  publication-title: Aging (Albany NY)
– volume: 302
  start-page: E134
  issue: 1
  year: 2012
  ident: key 20170807135912_B3
  article-title: Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00296.2011
– volume: 106
  start-page: 7149
  issue: 17
  year: 2009
  ident: key 20170807135912_B20
  article-title: Oxytocin is an anabolic bone hormone
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0901890106
– volume: 78
  start-page: 611
  issue: 6
  year: 2011
  ident: key 20170807135912_B24
  article-title: Oxytocin and bone remodelling: relationships with neuropituitary hormones, bone status and body composition
  publication-title: Joint Bone Spine
  doi: 10.1016/j.jbspin.2011.02.002
– volume: 11
  start-page: 125
  issue: 2
  year: 1988
  ident: key 20170807135912_B17
  article-title: Oxytocin response to insulin-induced hypoglycemia in obese subjects before and after weight loss
  publication-title: J Endocrinol Invest
  doi: 10.1007/BF03350119
– volume: 27
  start-page: 119
  issue: 1
  year: 2012
  ident: key 20170807135912_B43
  article-title: Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.506
– volume: 113
  start-page: 164
  issue: 1
  year: 2016
  ident: key 20170807135912_B22
  article-title: Functions of vasopressin and oxytocin in bone mass regulation
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1523762113
– volume: 51
  start-page: 1106
  issue: 6
  year: 1990
  ident: key 20170807135912_B38
  article-title: Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/51.6.1106
– volume: 23
  start-page: 950
  issue: 5
  year: 2015
  ident: key 20170807135912_B11
  article-title: Oxytocin reduces caloric intake in men
  publication-title: Obesity (Silver Spring)
  doi: 10.1002/oby.21069
– volume: 174
  start-page: 503
  issue: 4
  year: 2016
  ident: key 20170807135912_B34
  article-title: Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-15-0875
– start-page: e61477
  volume-title: PLoS One
  year: 2013
  ident: key 20170807135912_B13
  article-title: Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models
– volume: 16
  start-page: 460
  issue: 5
  year: 2005
  ident: key 20170807135912_B26
  article-title: Contributions of bone density and structure to fracture risk assessment in men and women
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-004-1820-1
– volume: 41
  start-page: 131
  issue: 4
  year: 2007
  ident: key 20170807135912_B23
  article-title: Possible neuroendocrine role for oxytocin in bone remodeling
  publication-title: Endocr Regul
– volume: 64
  start-page: 3
  issue: 1
  year: 1983
  ident: key 20170807135912_B35
  article-title: 1983 metropolitan height and weight tables
  publication-title: Stat Bull Metrop Life Found
– volume: 25
  start-page: 60
  issue: 1
  year: 1993
  ident: key 20170807135912_B37
  article-title: Measurement of physical activity to assess health effects in free-living populations
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/00005768-199301000-00010
– volume: 287
  start-page: 29159
  issue: 34
  year: 2012
  ident: key 20170807135912_B21
  article-title: Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M112.365049
– volume: 12
  start-page: 113
  issue: 1
  year: 1991
  ident: key 20170807135912_B6
  article-title: Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats
  publication-title: Peptides
  doi: 10.1016/0196-9781(91)90176-P
– volume: 23
  start-page: 1892
  issue: 12
  year: 2008
  ident: key 20170807135912_B27
  article-title: Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.080802
– volume: 37
  start-page: 311
  issue: 2
  year: 1983
  ident: key 20170807135912_B36
  article-title: Elbow breadth as a measure of frame size for US males and females
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/37.2.311
– volume: 99
  start-page: E881
  issue: 5
  year: 2014
  ident: key 20170807135912_B15
  article-title: Oxytocin secretion is related to measures of energy homeostasis in young amenorrheic athletes
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-4136
– volume: 10
  start-page: 89
  issue: 1
  year: 1989
  ident: key 20170807135912_B5
  article-title: Influence of oxytocin on feeding behavior in the rat
  publication-title: Peptides
  doi: 10.1016/0196-9781(89)90082-X
– volume: 164
  start-page: 253
  issue: 2
  year: 2011
  ident: key 20170807135912_B31
  article-title: Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-10-0523
– volume: 40
  start-page: 1707
  issue: 11
  year: 2016
  ident: key 20170807135912_B12
  article-title: Oxytocin’s inhibitory effect on food intake is stronger in obese than normal-weight men
  publication-title: Int J Obes
  doi: 10.1038/ijo.2016.149
– reference: 2349926 - Am J Clin Nutr. 1990 Jun;51(6):1106-12
– reference: 3283208 - J Endocrinol Invest. 1988 Feb;11(2):125-8
– reference: 26903591 - Eur J Endocrinol. 2016 Apr;174(4):503-12
– reference: 24384013 - J Clin Endocrinol Metab. 2014 Jan;99(1):30-8
– reference: 6623350 - Stat Bull Metrop Life Found. 1983 Jan-Jun;64(1):3-9
– reference: 2819958 - Regul Pept. 1987 Jul;18(1):7-18
– reference: 25233153 - J Clin Endocrinol Metab. 2014 Dec;99(12):4683-9
– reference: 24446658 - J Clin Endocrinol Metab. 2014 Apr;99(4):E634-41
– reference: 18520999 - Neuroreport. 2008 Jun 11;19(9):951-5
– reference: 22761429 - J Biol Chem. 2012 Aug 17;287(34):29159-67
– reference: 23512706 - Obesity (Silver Spring). 2013 Dec;21(12):2458-64
– reference: 19837921 - J Clin Endocrinol Metab. 2009 Dec;94(12):4710-6
– reference: 22184277 - Aging (Albany NY). 2011 Dec;3(12):1169-77
– reference: 26171799 - J Clin Endocrinol Metab. 2015 Sep;100(9):3313-21
– reference: 21394495 - Osteoporos Int. 2012 Feb;23(2):543-51
– reference: 26699482 - Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):164-9
– reference: 23258269 - Eur J Endocrinol. 2013 Feb 20;168(3):457-64
– reference: 2748428 - Peptides. 1989 Jan-Feb;10(1):89-93
– reference: 21903023 - J Clin Psychiatry. 2011 Nov;72(11):1546-51
– reference: 18684092 - J Bone Miner Res. 2008 Dec;23(12):1892-904
– reference: 25565097 - Horm Metab Res. 2015 Jul;47(8):600-4
– reference: 21781144 - Clin Endocrinol (Oxf). 2012 Apr;76(4):520-5
– reference: 21828335 - Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E1004-12
– reference: 25865294 - Obesity (Silver Spring). 2015 May;23(5):950-6
– reference: 21441053 - Joint Bone Spine. 2011 Dec;78(6):611-5
– reference: 21098684 - Eur J Endocrinol. 2011 Feb;164(2):253-61
– reference: 25062461 - J Clin Endocrinol Metab. 2014 Dec;99(12):4664-73
– reference: 18257653 - Endocr Regul. 2007 Nov;41(4):131-41
– reference: 21915902 - J Bone Miner Res. 2012 Jan;27(1):119-24
– reference: 19369205 - Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7149-54
– reference: 22008455 - Am J Physiol Endocrinol Metab. 2012 Jan 1;302(1):E134-44
– reference: 24606095 - J Clin Endocrinol Metab. 2014 May;99(5):E881-5
– reference: 18583541 - Stem Cells. 2008 Sep;26(9):2399-407
– reference: 24915299 - Nat Commun. 2014 Jun 10;5:4082
– reference: 27553712 - Int J Obes (Lond). 2016 Nov;40(11):1707-1714
– reference: 1646995 - Peptides. 1991 Jan-Feb;12(1):113-8
– reference: 15688123 - Osteoporos Int. 2005 May;16(5):460-7
– reference: 8423758 - Med Sci Sports Exerc. 1993 Jan;25(1):60-70
– reference: 18280192 - J Clin Densitom. 2008 Apr-Jun;11(2):232-6
– reference: 9401539 - Acta Paediatr Suppl. 1997 Nov;423:50-4
– reference: 2744933 - Int J Obes. 1989;13(2):213-22
– reference: 21980491 - PLoS One. 2011;6(9):e25565
– reference: 6823895 - Am J Clin Nutr. 1983 Feb;37(2):311-4
– reference: 23700406 - PLoS One. 2013 May 20;8(5):e61477
SSID ssj0014453
Score 2.446868
Snippet ContextOxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia...
Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa...
Abstract Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia...
Oxytocin levels are elevated in women with obesity compared with normal-weight women, are a marker of energy availability, and may be a mediator of bone...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2814
SubjectTerms Absorptiometry
Absorptiometry, Photon
Adult
Anorexia
Anorexia Nervosa - metabolism
Body Composition
Body Mass Index
Body weight
Bone composition
Bone Density
Bone mineral density
Clinical s
Cross-Sectional Studies
Dual energy X-ray absorptiometry
Eating disorders
Energy
Female
Geometry
Hip
Hip - diagnostic imaging
Hormones
Humans
Hypothalamus
Intra-Abdominal Fat - diagnostic imaging
Obesity
Obesity - metabolism
Osteoporosis
Overweight
Oxytocin
Oxytocin - metabolism
Spine
Spine - diagnostic imaging
Subcutaneous Fat - diagnostic imaging
Weight
Young Adult
Title Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-201708000-00020
https://www.ncbi.nlm.nih.gov/pubmed/28586943
https://www.proquest.com/docview/1969998701
https://www.proquest.com/docview/3164380642
https://www.proquest.com/docview/1907000116
https://pubmed.ncbi.nlm.nih.gov/PMC5546854
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxASQnyOwJiMBE_MIont2HlCG2wUpA6EmOhb5MSO1sGSsmaC_vfcOW5YBOO1PqdJ7iP38_18JuS5kbwWlbYsyRQAlNTGzNR5xgSPra0Vl9bv4p8eZZNj8WEmZ2HBbRloleuY6AO1bStcI3-FbVwAGqg4eb34wfDUKKyuhiM0rpNNbF2GlC41GwAXYIXQhRJpCCqdBeI77lo5xfaFScZ4nvHRJ2m0ze1Stvk3afLWzxYL2stvns9-6at0eIfcDukk3ev1f5dcc809cmMaCub3Sffx16qD999Q01j6vlvSgf12Ml_QrqX7rV1RjAqBvbULvzSOTue-HTV9iwT3brXr509gyjvXnrnufEX3_NNQSCDpV7--SvEs--784uwBOT48-PJmwsJBC6wSKgf4mAGoSaragUdz5azUdZppA94vUpfHujK6rE1pQa4WkI7b0qXacGkAT-Y8dvwh2Wjg3h4Rah1cy9hSZioV0qhccyuFqiFLMq5KbURert91UYUu5HgYxvcC0QhopjitCtRMgZqJyItBetF337hCjoLarhJhvcj2WqdFcNNl8ceo_jnMAUtyjRAtIs-GYfA_LKqYxrUXeAkImr6cFZGt3kKG-0i11Fku4L_VyHYGAeztPR5p5ie-xzeSB7UUEWEjKyv63bGFh3aQZ0CQSxQm_b49QBo__v9TPiE3cUJPYNwmG2AT7ikkVV254z1nh2zuHxx9-vwbsO8eFg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELZGJ8EkhPg5CgOMxJ5YRGo7sfOA0MY2WrYWBJvoW3BiR-tgSVkzjfxT_I3cOWlYBeNtr_XZTXLny325786EvNABz0SqjNcLJQAUZnxPZ1HoCe4bk0keGFfFPxyF_UPxfhyMl8iveS0M0irnPtE5alOk-I38FbZxAWgg_d6b6Q8PT43C7Or8CI3aLPZsdQ6QbfZ6sA36XWdsd-fgbd9rThXwUiEjwEohRPC9NLNgvlxaE6iMhUqDqQtmI1-lWiWZTgzIZQJiT5NYpjQPNICniPuWw7rXyLLgAGU6ZHlrZ_TxU5u3EKLpe4nEB8nGDdUe62SOsWFiL_R4FPKFl-BCYd2F-PZvmubN8wJT6LNvjkF_4T24e5vcagJYullb3B2yZPO75PqwSdHfI-WHn1UJGs-pzg0dlDPa8u2OJlNaFnSrMBVFP9TwxTbgl9zS4cQ1wKbbSKkvqw03vw9T3tnixJanFd10d0MhZKVf3Bdd-hnrRE_PTu6TwytRwgPSyeHaHhJqLKylTRKEkolAy0hxEwiZQVymbcpMl7ycP-s4bfqe4_Eb32PEP6CZ-DiNUTMxaqZL1lvpad3v4xI5Cmq7TMSrRdbmOo0bxzCL_5jxP4c5oFeuEBR2yfN2GHY8pnF0boszXALctEugdclqbSHtdTAVqDAS8N9ywXZaAewmvjiST45cV3GkK6pAdIm3YGVxXY8bOzAJkQ241Z5EmOEaEjD_0f_v8hm50T8Y7sf7g9HeY7KCk2v65BrpgH3YJxDSlcnTZh9R8vWqt-5vA5xZSQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxytocin+and+Its+Relationship+to+Body+Composition%2C+Bone+Mineral+Density%2C+and+Hip+Geometry+Across+the+Weight+Spectrum&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Schorr%2C+Melanie&rft.au=Marengi%2C+Dean+A.&rft.au=Pulumo%2C+Reitumetse+L.&rft.au=Yu%2C+Elaine&rft.date=2017-08-01&rft.pub=Endocrine+Society&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=102&rft.issue=8&rft.spage=2814&rft.epage=2824&rft_id=info:doi/10.1210%2Fjc.2016-3963&rft_id=info%3Apmid%2F28586943&rft.externalDocID=PMC5546854
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon